Australia markets closed

Firebrick Pharma Limited (FRE.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0620-0.0030 (-4.62%)
At close: 03:49PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
Total revenue
0.83
0.83
4.124
Gross profit
0.83
0.83
4.124
Operating expenses
Research development
4,091
4,091
2,217
Selling general and administrative
659.934
659.934
829.315
Total operating expenses
6,865
6,865
4,877
Operating income or loss
-6,864
-6,864
-4,873
Interest expense
-
-
4.144
Total other income/expenses net
21.72
21.72
1,079
Income before tax
-6,802
-6,802
-3,796
Income tax expense
0
0
0
Income from continuing operations
-6,802
-6,802
-3,796
Net income
-6,802
-6,802
-3,796
Net income available to common shareholders
-6,802
-6,802
-3,796
Basic EPS
-0.04
-
-0.03
Diluted EPS
-0.04
-
-0.03
Basic average shares
170,092
-
116,519
Diluted average shares
170,092
-
116,519